Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics
Rune A. Kroken, Iris E. Sommer, Vidar M. Steen, et al.
Frontiers in Psychiatry (2019) Vol. 9
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation
Ashley L. Comer, Micaël Carrier, Marie‐Ève Tremblay, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 173
Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders
Somarani Dash, Yasir Ahmed Syed, Mojibur R. Khan
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 108
Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway
Alexandre Vallée
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2810-2810
Open Access | Times Cited: 88
Increased densities of T and B lymphocytes indicate neuroinflammation in subgroups of schizophrenia and mood disorder patients
Konstantin Schlaaff, Henrik Dobrowolny, Thomas Frodl, et al.
Brain Behavior and Immunity (2020) Vol. 88, pp. 497-506
Closed Access | Times Cited: 85
An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events
Marika Cordaro, Salvatore Cuzzocrea, Rosalia Crupi
Antioxidants (2020) Vol. 9, Iss. 3, pp. 216-216
Open Access | Times Cited: 81
Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment
Marcella Reale, Erica Costantini, Nigel H. Greig
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 76
The role of glial cells in mental illness: a systematic review on astroglia and microglia as potential players in schizophrenia and its cognitive and emotional aspects
Daniela Laricchiuta, Martina Papi, Davide Decandia, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 11
Dysregulation of synaptic pruning as a possible link between intestinal microbiota dysbiosis and neuropsychiatric disorders
Ahmed Eltokhi, Isabel E. Janmaat, Mohamed Genedi, et al.
Journal of Neuroscience Research (2020) Vol. 98, Iss. 7, pp. 1335-1369
Open Access | Times Cited: 70
Large-Scale Evidence for an Association Between Peripheral Inflammation and White Matter Free Water in Schizophrenia and Healthy Individuals
Maria A. Di Biase, Andrew Zalesky, Suheyla Cetin‐Karayumak, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 2, pp. 542-551
Open Access | Times Cited: 68
Viral respiratory infections and psychosis: A review of the literature and the implications of COVID-19
Stephanie S. Kulaga, Christopher W. T. Miller
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 520-530
Open Access | Times Cited: 47
Mortality from coronavirus disease 2019 (Covid-19) in patients with schizophrenia: A systematic review, meta-analysis and meta-regression
Engelberta Pardamean, Waskita Roan, Karina Terry Amartini Iskandar, et al.
General Hospital Psychiatry (2022) Vol. 75, pp. 61-67
Open Access | Times Cited: 32
Shared Genetic Loci Between Schizophrenia and White Blood Cell Counts Suggest Genetically Determined Systemic Immune Abnormalities
Nils Eiel Steen, Zillur Rahman, Attila Szabó, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 5, pp. 1345-1354
Open Access | Times Cited: 17
The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice
Meghan May, Megan Beauchemin, Calvin Vary, et al.
PLoS ONE (2019) Vol. 14, Iss. 6, pp. e0218937-e0218937
Open Access | Times Cited: 46
Psychotic-like Experiences and Polygenic Liability in the Adolescent Brain Cognitive Development Study
Nicole R. Karcher, Sarah E. Paul, Emma C. Johnson, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2021) Vol. 7, Iss. 1, pp. 45-55
Open Access | Times Cited: 36
Cytokine Imbalance as a Biomarker of Treatment-Resistant Schizophrenia
N. А. Shnayder, Aiperi K. Khasanova, Anna Strelnik, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11324-11324
Open Access | Times Cited: 24
Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines
Caitlin E. Murphy, Adam J. Lawther, Maree J. Webster, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 39
Longitudinal study of inflammatory markers and psychopathology in schizophrenia
Tami Feng, Joseph P. McEvoy, Brian J. Miller
Schizophrenia Research (2020) Vol. 224, pp. 58-66
Closed Access | Times Cited: 34
Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets
Matej Ľupták, Danica Michaličková, Zdeněk Fišar, et al.
World Journal of Psychiatry (2021) Vol. 11, Iss. 7, pp. 277-296
Open Access | Times Cited: 30
Immune marker levels in severe mental disorders: associations with polygenic risk scores of related mental phenotypes and psoriasis
Maren Caroline Frogner Werner, Katrine V. Wirgenes, Alexey Shadrin, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Microglia sequelae: brain signature of innate immunity in schizophrenia
Ana Catarina Rodrigues‐Neves, António Francisco Ambrósio, Catarina A. Gomes
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Emergency department visits associated with wildfire smoke events in California, 2016–2019
Annie I. Chen, Keita Ebisu, Tarik Benmarhnia, et al.
Environmental Research (2023) Vol. 238, pp. 117154-117154
Open Access | Times Cited: 13
Natural products-based polypharmacological modulation of the peripheral immune system for the treatment of neuropsychiatric disorders
Simon Wing-Fai Mok, Vincent Kam Wai Wong, Hang Hong Lo, et al.
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107480-107480
Closed Access | Times Cited: 32
Elevated zonulin, a measure of tight-junction permeability, may be implicated in schizophrenia
Gregory Barber, Craig Sturgeon, Alessio Fasano, et al.
Schizophrenia Research (2019) Vol. 211, pp. 111-112
Closed Access | Times Cited: 31
Limited evidence of association between dysregulated immune marker levels and telomere length in severe mental disorders
Monica Bettina Elkjær Greenwood Ormerod, Thor Ueland, Monica Aas, et al.
Acta Neuropsychiatrica (2025) Vol. 37
Closed Access
Sex differences in the peripheral levels of cytokines during 12-month antipsychotic treatment in a drug-naïve schizophrenia spectrum cohort
I. Ratke, A. Torsvik, C.A. Bartz-Johannessen, et al.
Brain Behavior & Immunity - Health (2025) Vol. 44, pp. 100959-100959
Open Access
Page 1 - Next Page

Scroll to top